了解癌症干细胞维护和治疗耐药性的自功能
1Department of Biochemistry, University of Lucknow, Lucknow 226007, India.
Expert reviews in molecular medicine
|October 8, 2024
概括
自促进癌症干细胞 (CSC) 的特征,增强瘤生长和治疗耐药性. 阻断自可能提供一种治疗策略,通过抑制癌细胞的可塑性来消除癌细胞.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 细胞应激反应的应激反应
背景情况:
- 瘤微环境 (TME) 和它与瘤细胞的相互作用驱动癌症的进展和治疗失败.
- 在TME内的代谢变化,如缺氧和营养物质波动,诱导癌症干细胞 (CSC) 特性.
- 自在癌细胞存活,休眠,转移和抗疗方面发挥着至关重要的作用.
研究的目的:
- 审查通过自诱导癌症干细胞 (CSC) 现型的机制.
- 探索自在促进CSC攻击性和治疗耐药性的作用.
- 讨论阻断自作为一种潜在的治疗策略来对抗癌症.
主要方法:
- 关于自,癌症干细胞和瘤微环境的最新研究的文献综述.
- 对自与CSC诱导和可塑性联系的机制的分析.
- 在癌症治疗中检查针对自的治疗策略.
主要成果:
- 自与促进纤维细胞生产,干细胞和癌细胞在压力下存活有关.
- 自促进了CSC休眠状态,上皮细胞-介质细胞过渡和侵入性.
- 自有助于治疗耐药性和瘤强度.
结论:
- 自是CSC表型和攻击性的关键调节者.
- 向自是一种有希望的策略,通过抑制其可塑性来克服治疗阻力并消除癌细胞.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Delivery Pathways to the Lysosome
6.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K


